Methods of making 6-(4,5-dihydro-1h-imidazol-2-yl)amino--7-methyl-1h-benzimidazole-4-carbonitrile and its preferred salt form
CA 2517002 C · Owner: Curtis, Michael David · Inventors: Curtis, Michael David; Randall, Jared Lynn; Nikolaides, Nicholas
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
6-(4,5-Dihydro-1H-imidazol-2-yl)amino--7-methyl-1H-benzimidazole-4carbonitrile substantially free of 2,3,7-triamino-4,6-dimethyl-1,9phenazinedicarbonitrile, and the anhydrous monoacetate salt thereof are , useful in the treatment of alpha-2 mediated disorders such as ocular hypertension.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed February 20, 2004 and granted July 8, 2014. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended February 20, 2024.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by February 20, 2026.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.